Cargando…
INPP5D/SHIP1: Expression, Regulation and Roles in Alzheimer’s Disease Pathophysiology
Alzheimer’s disease (AD) is the most common form of dementia, accounting for approximately 38.5 million cases of all-cause dementia. Over 60% of these individuals live in low- and middle-income countries and are the worst affected, especially by its deleterious effects on the productivity of both pa...
Autores principales: | Olufunmilayo, Edward O., Holsinger, R. M. Damian |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10606568/ https://www.ncbi.nlm.nih.gov/pubmed/37895194 http://dx.doi.org/10.3390/genes14101845 |
Ejemplares similares
-
Roles of Non-Coding RNA in Alzheimer’s Disease Pathophysiology
por: Olufunmilayo, Edward O., et al.
Publicado: (2023) -
Microglial function, INPP5D/SHIP1 signaling, and NLRP3 inflammasome activation: implications for Alzheimer’s disease
por: Terzioglu, Gizem, et al.
Publicado: (2023) -
Expression of INPP5D Isoforms in Human Brain: Impact of Alzheimer’s Disease Neuropathology and Genetics
por: Zajac, Diana J., et al.
Publicado: (2023) -
INPP5D regulates inflammasome activation in human microglia
por: Chou, Vicky, et al.
Publicado: (2023) -
Microglial INPP5D limits plaque formation and glial
reactivity in the PSAPP mouse model of Alzheimer’s
disease
por: Castranio, Emilie L., et al.
Publicado: (2023)